Berlin-based startup Hale has secured €350K in pre-seed funding to redefine women’s pain management. Founded in 2022 by Gaia Salizzoni and Vittoria Brolis, Hale is on a mission to revolutionize patient care through a home-care management app designed to guide genito-pelvic patients throughout their health journey. With a focus on scientific evidence, data integration, and collaboration with existing healthcare systems, Hale aims…
French biotech company Ziwig has achieved a significant breakthrough in the field of endometriosis diagnosis with the validation of their Ziwig Endotest as a highly effective diagnostic tool. The study, published in the renowned New England Journal of Medicine (NEJM) Evidence, confirms the performance and reproducibility of Ziwig Endotest, boasting sensitivity and specificity rates exceeding 95%. This non-invasive test offers an alternative…
Researchers at the Royal Hospital for Women in Sydney (Australia) have made a groundbreaking breakthrough in the diagnosis and treatment of endometriosis. By successfully cultivating tissue samples representing all known types of endometriosis within a laboratory setting, tfhe team has could observe cellular transformations and compare tissue responses to various treatments. This newfound understanding holds tremendous potential for doctors to enhance the…
